These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34244869)

  • 1. Screen-detected breast cancer is associated with better prognosis and survival compared to self-detected/symptomatic cases in a Chilean cohort of female patients.
    Walbaum B; Puschel K; Medina L; Merino T; Camus M; Razmilic D; Navarro ME; Dominguez F; Cordova-Delgado M; Pinto MP; Acevedo F; Sánchez C
    Breast Cancer Res Treat; 2021 Sep; 189(2):561-569. PubMed ID: 34244869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular subtypes of screen-detected breast cancer.
    Farshid G; Walters D
    Breast Cancer Res Treat; 2018 Nov; 172(1):191-199. PubMed ID: 30046938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular comparison of interval and screen-detected breast cancers.
    Cheasley D; Li N; Rowley SM; Elder K; Mann GB; Loi S; Savas P; Goode DL; Kader T; Zethoven M; Semple T; Fox SB; Pang JM; Byrne D; Devereux L; Nickson C; Procopio P; Lee G; Hughes S; Saunders H; Fujihara KM; Kuykhoven K; Connaughton J; James PA; Gorringe KL; Campbell IG
    J Pathol; 2019 Jun; 248(2):243-252. PubMed ID: 30746706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of risk factors and prognostic features between symptomatic and screen detected breast cancer.
    Burke JP; Power C; Gorey TF; Flanagan F; Kerin MJ; Kell MR
    Eur J Surg Oncol; 2008 Feb; 34(2):149-53. PubMed ID: 17498912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics, risk factors, and outcomes in Chilean triple negative breast cancer patients: a real-world study.
    Acevedo F; Walbaum B; Medina L; Merino T; Camus M; Puschel K; Ramírez K; Manzor M; Veglia P; Martinez R; Guerra C; Navarro M; Bauerle C; Dominguez F; Sánchez C
    Breast Cancer Res Treat; 2023 Jan; 197(2):449-459. PubMed ID: 36414796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
    Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
    Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are symptomatic guidelines for chemotherapy appropriate to ER-positive screen-detected breast cancer (SDBC)?
    Bundred NJ; Prasad R; Morris J; Knox WF; Byrne G; Cheung S; Wilson M; Lawrence G
    Breast Cancer Res Treat; 2013 Apr; 138(2):359-68. PubMed ID: 21744241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do screen-detected breast cancers have positive margins less often than clinically detected breast cancers?
    de Munck L; Siesling S; Bart J; Menke-Pluijmers MB; Otter R; Willemse PH
    Eur J Cancer Prev; 2013 Sep; 22(5):398-403. PubMed ID: 23492953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in subtype distribution between screen-detected and symptomatic invasive breast cancer and their impact on survival.
    Kobayashi N; Hikichi M; Ushimado K; Sugioka A; Kiriyama Y; Kuroda M; Utsumi T
    Clin Transl Oncol; 2017 Oct; 19(10):1232-1240. PubMed ID: 28409323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammography screening is associated with more favourable breast cancer tumour characteristics and better overall survival: case-only analysis of 3739 Asian breast cancer patients.
    Lim ZL; Ho PJ; Khng AJ; Yeoh YS; Ong ATW; Tan BKT; Tan EY; Tan SM; Lim GH; Lee JA; Tan VK; Hu J; Li J; Hartman M
    BMC Med; 2022 Aug; 20(1):239. PubMed ID: 35922814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast Cancer Subtypes in Northern Thailand and Barriers to satisfactory survival outcomes.
    Ditsatham C; Sripan P; Chaiwun B; Klunklin P; Tharavichitkul E; Chakrabandhu S; Muangwong P; Chitapanarux I
    BMC Cancer; 2022 Nov; 22(1):1147. PubMed ID: 36348356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severity and risk factors of interval breast cancer in Queensland, Australia: a population-based study.
    Kou K; Cameron J; Youl P; Pyke C; Chambers S; Dunn J; Aitken JF; Baade PD
    Breast Cancer; 2023 May; 30(3):466-477. PubMed ID: 36809492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
    Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
    JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does breast screening offer a survival benefit? A retrospective comparative study of oncological outcomes of screen-detected and symptomatic early stage breast cancer cases.
    Újhelyi M; Pukancsik D; Kelemen P; Kovács E; Kenessey I; Udvarhelyi N; Bak M; Kovács T; Mátrai Z
    Eur J Surg Oncol; 2016 Dec; 42(12):1814-1820. PubMed ID: 27424787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammography correlates to better survival rates in breast cancer patients: a 20-year experience in a University health institution.
    Maiz C; Silva F; Domínguez F; Galindo H; Camus M; León A; Oddó D; Villarroel A; Razmilic D; Navarro ME; Medina L; Merino T; Vines E; Peña J; Maldonado D; Pinto MP; Acevedo F; Sánchez C
    Ecancermedicalscience; 2020; 14():1005. PubMed ID: 32104207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between screen-detected and symptomatic breast cancers according to molecular subtypes.
    Kim J; Lee S; Bae S; Choi MY; Lee J; Jung SP; Kim S; Choe JH; Kim JH; Kim JS; Lee JE; Nam SJ; Yang JH
    Breast Cancer Res Treat; 2012 Jan; 131(2):527-40. PubMed ID: 22042364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic therapy and prognosis of older patients with stage II/III breast cancer: A large-scale analysis of the Japanese Breast Cancer Registry.
    Yamada A; Kumamaru H; Shimizu C; Taira N; Nakayama K; Miyashita M; Honma N; Miyata H; Endo I; Saji S; Sawaki M
    Eur J Cancer; 2021 Sep; 154():157-166. PubMed ID: 34293663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients.
    Koh VC; Lim JC; Thike AA; Cheok PY; Thu MM; Tan VK; Tan BK; Ong KW; Ho GH; Tan WJ; Tan Y; Salahuddin AS; Busmanis I; Chong AP; Iqbal J; Thilagaratnam S; Wong JS; Tan PH
    Breast Cancer Res Treat; 2015 Jul; 152(2):293-304. PubMed ID: 26077641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in advanced breast cancer after introduction of a mammography screening program in Tyrol/Austria.
    Oberaigner W; Geiger-Gritsch S; Edlinger M; Daniaux M; Knapp R; Hubalek M; Siebert U; Marth C; Buchberger W
    Breast; 2017 Jun; 33():178-182. PubMed ID: 28419909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.